CM4 is an orally administered proprietary glycoside formulation for the immune system.
For more information:
 • General Information
• Research
• Specifications
• Recommended Usage
• Mechanisms of Action
• Toxicology
• Genotoxicity
• Carcinogenicity
• Adverse Events
• Contraindications
• CM4 Quick Facts (Adobe Acrobat PDF)
|
|
PCM-4 is a three component combination product comprised of polypeptides (in a tablet formulation), glycosides (in a capsule formulation), and glycosides (in a liquid formulation). PCM-4 is being re-developed in a new dosage form that would combine the polypeptides and glycopeptides providing a time release unit dose.
For more information:
• General Information
• Research
• Recommended Usage
|
